Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the presentation of ...

The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease ...

FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, reported today its Fiscal 2024 results. FONAR’s primary ...

Analyst Dylan Van Haaften from Stifel Nicolaus reiterated a Buy rating on Siemens Healthineers AG (SEMHF – Research Report) and keeping ...

An ultrasound gives providers a better view of internal organs. They’re used to help diagnose conditions and monitor ...

In a report released today, David Adlington from J.P. Morgan maintained a Buy rating on Siemens Healthineers AG (SEMHF – Research ...

Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving ...

Government proposals to further regulate the health industry have been condemned by medics in the private sector. Under ...

One key factor is the emergence of technologies such as liquid biopsies and genomic testing. A rising prevalence of the ...

Earnings season has unveiled promising opportunities in health stocks, with Telix and CSL standing out as key gems.